PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extracts of A. purpurata were proven to be alternative solutions for treating C. krusei resistance [PMID:37898844]
Leaf subextracts demonstrated in vitro inhibitory activity against M. tuberculosis [PMID:21120040]
Ethyl acetate leaf extract showed potential anticancer activity with a half maximal inhibitory concentration (IC50) of 110.25 μg/mL at 48 hours [PMID:23257141]
The lectin ApuL showed bacteriostatic activity against S. aureus and fungistatic effects against C. albicans and C. parapsilosis [PMID:30142463]
Kumatakenin significantly alleviated symptoms and suppressed intestinal inflammation by inhibiting ferroptosis [PMID:37006994]
Evidence summary
PubMed sources
- 1.PMID: 26559362 (2015) — Phytochemistry and pharmacology of ornamental gingers, Hedychium coronarium and Alpinia purpurata: a review. · Journal of integrative medicine
- 2.PMID: 27038825 (2016) — Deep sequencing of banana bract mosaic virus from flowering ginger (Alpinia purpurata) and development of an immunocapture RT-LAMP detection assay. · Archives of virology
- 3.PMID: 37898844 (2023) — The Antifungal Activities of Syzygium aromaticum and Alpinia purpurata Extracts Against Candida krusei: Bioactivity Tests, Molecular Modeling, and Toxicity Tests. · Asian Pacific journal of cancer prevention : APJCP
- 4.PMID: 21120040 (2010) — Phytoconstituents from Alpinia purpurata and their in vitro inhibitory activity against Mycobacterium tuberculosis. · Pharmacognosy magazine
- 5.PMID: 25141816